Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer

Table 3 Clinical data of 34 cervical SCC patients who received NACT before surgery (n = 34)

Patients	Age (year)	Selection date	Clinical stage	NACT efficacy
1	45	2012.1.27	Stage I_b2	Effective
2	34	2012.2.4	Stage IIa	Effective
3	36	2012.3.12	Stage IIb	Effective
4	47	2012.4.15	Stage I_b2	Not effective
5	57	2012.4.17	Stage I_b2	Effective
6	39	2012.5.15	Stage IIa	Effective
7	45	2012.5.18	Stage IIa	Effective
8	42	2012.6.3	Stage IIb	Not effective
9	32	2012.6.17	Stage I_b2	Effective
10	66	2012.6.26	Stage IIa	Not effective
11	59	2012.7.14	Stage IIb	Not effective
12	46	2012.8.4	Stage I_b2	Effective
13	49	2012.8.15	Stage IIa	Not effective
14	51	2012.8.24	Stage I_b2	Effective
15	35	2012.8.29	Stage I_b2	Effective
16	38	2012.9.16	Stage IIa	Not effective
17	40	2012.9.19	Stage I_b2	Effective
18	43	2012.10.7	Stage IIa	Effective
19	58	2012.10.11	Stage IIb	Effective
20	63	2012.10.17	Stage IIa	Not effective
21	53	2012.10.19	Stage I_b2	Effective
22	48	2012.10.25	Stage I_b2	Effective
23	43	2012.10.28	Stage IIa	Effective
24	45	2012.11.1	Stage IIb	Not effective
25	44	2012.11.5	Stage IIa	Effective
26	61	2012.11.16	Stage I_b2	Not effective
27	39	2012.11.23	Stage IIa	Effective
28	67	2012.11.25	Stage IIa	Effective
29	56	2012.11.30	Stage I_b2	Effective
30	44	2012.12.2	Stage I_b2	Effective
31	33	2012.12.10	Stage IIa	Not effective
32	54	2012.12.15	Stage I_b2	Effective
33	57	2012.12.19	Stage IIa	Effective
34	49	2012.12.22	Stage I_b2	Effective

ISSN: 1746-1596